FOLR1 expression
|
Ovarian Cancer
|
FOLR1 expression
|
Ovarian Cancer
|
IMGN 853 Sensitive: B - Late Trials
|
IMGN 853 Sensitive: B - Late Trials
|
FOLR1 expression
|
Solid Tumor
|
FOLR1 expression
|
Solid Tumor
|
MORAb-202 Sensitive: C2 – Inclusion Criteria
|
MORAb-202 Sensitive: C2 – Inclusion Criteria
|
FOLR1 expression
|
Endometrial Cancer
|
FOLR1 expression
|
Endometrial Cancer
|
IMGN 853 Sensitive: C3 – Early Trials
|
IMGN 853 Sensitive: C3 – Early Trials
|
FOLR1 expression
|
Ovarian Cancer
|
FOLR1 expression
|
Ovarian Cancer
|
rucaparib + IMGN 853 Sensitive: C3 – Early Trials
|
rucaparib + IMGN 853 Sensitive: C3 – Early Trials
|
FOLR1 expression
|
Endometrial Cancer
|
FOLR1 expression
|
Endometrial Cancer
|
rucaparib + IMGN 853 Sensitive: C3 – Early Trials
|
rucaparib + IMGN 853 Sensitive: C3 – Early Trials
|
FOLR1 expression
|
AML
|
FOLR1 expression
|
AML
|
ELU001 Sensitive: D – Preclinical
|
ELU001 Sensitive: D – Preclinical
|